Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus-Induced Insulin Resistance

Insulin resistance and type 2 diabetes are associated with hepatitis C virus infection. A wealth of clinical and experimental data suggests that the virus is directly interfering with the insulin signalling in hepatocytes. In the case of at least one viral genotype (the type 3a), insulin resistance...

Full description

Saved in:
Bibliographic Details
Main Author: Francesco Negro
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:PPAR Research
Online Access:http://dx.doi.org/10.1155/2009/483485
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832555412415578112
author Francesco Negro
author_facet Francesco Negro
author_sort Francesco Negro
collection DOAJ
description Insulin resistance and type 2 diabetes are associated with hepatitis C virus infection. A wealth of clinical and experimental data suggests that the virus is directly interfering with the insulin signalling in hepatocytes. In the case of at least one viral genotype (the type 3a), insulin resistance seems to be directly mediated by the downregulation of the peroxisome proliferator-activated receptor γ. Whether and how this interaction may be manipulated pharmacologically, in order to improve the responsiveness to antivirals of insulin resistant chronic hepatitis C, patients remain to be fully explored.
format Article
id doaj-art-34041ded05aa4fe1990815b3fca25efe
institution Kabale University
issn 1687-4757
1687-4765
language English
publishDate 2009-01-01
publisher Wiley
record_format Article
series PPAR Research
spelling doaj-art-34041ded05aa4fe1990815b3fca25efe2025-02-03T05:48:16ZengWileyPPAR Research1687-47571687-47652009-01-01200910.1155/2009/483485483485Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus-Induced Insulin ResistanceFrancesco Negro0Viropathology Unit, University of Geneva Medical Center, 1211 Geneva, SwitzerlandInsulin resistance and type 2 diabetes are associated with hepatitis C virus infection. A wealth of clinical and experimental data suggests that the virus is directly interfering with the insulin signalling in hepatocytes. In the case of at least one viral genotype (the type 3a), insulin resistance seems to be directly mediated by the downregulation of the peroxisome proliferator-activated receptor γ. Whether and how this interaction may be manipulated pharmacologically, in order to improve the responsiveness to antivirals of insulin resistant chronic hepatitis C, patients remain to be fully explored.http://dx.doi.org/10.1155/2009/483485
spellingShingle Francesco Negro
Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus-Induced Insulin Resistance
PPAR Research
title Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus-Induced Insulin Resistance
title_full Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus-Induced Insulin Resistance
title_fullStr Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus-Induced Insulin Resistance
title_full_unstemmed Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus-Induced Insulin Resistance
title_short Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus-Induced Insulin Resistance
title_sort peroxisome proliferator activated receptors and hepatitis c virus induced insulin resistance
url http://dx.doi.org/10.1155/2009/483485
work_keys_str_mv AT francesconegro peroxisomeproliferatoractivatedreceptorsandhepatitiscvirusinducedinsulinresistance